New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

The only update for patients with stage IV NSCLC without driver alterations is that patients who have HER2-overexpressing (IHC 3+) disease and good performance status can receive trastuzumab ...

Research assessing the nutritional status and impact of interventions for patients with lung cancer found that most exhibit ...

In a new study that challenges long-held views on lung cancer, University of Kentucky Markey Cancer Center researchers have ...

Lung cancer rates vary by subtype and adenocarcinoma incidence worldwide, likely due to differences in air pollution, smoking, and generational patterns.

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

The CDC says in the U.S. about 10 to 20 percent of lung cancers are found in non-smokers. That also includes people smoking ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Carcinoma is a type of cancer that starts in cells that make up ... Some examples of cancers that can be adenocarcinomas include lung, pancreatic, and colorectal types.

Treatment with CAN-2409, an off-the-shelf immunotherapy, elicited responses among patients with pretreated stage 3/4 ...

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

In a new study that challenges long-held views on lung cancer, University of Kentucky Markey Cancer Center researchers have discovered a surprising ...